VOLUME 61   2000   NUMBER 10

Brainstorms

710 The New Cholinesterase Inhibitors for Alzheimer's Disease, Part 1: Their Similarities Are Different. Stephen M. Stahl
[PDF]

Original Articles

712 How Fast Are Antidepressants? Alan J. Gelenberg and Chelsea L. Chesen
[Abstract] [PDF]

722 Efficacy, Adverse Events, and Treatment Discontinuations in Fluoxetine Clinical Studies of Major Depression: A Meta-Analysis of the 20-mg/day Dose.Charles M. Beasley, Jr., Mary E. Nilsson, Stephanie C. Koke, and Jill S. Gonzales
[Abstract] [PDF]

729 Prodromal Symptoms of Relapse in a Sample of Egyptian Schizophrenic Patients. Ahmed Okasha, Zeinab Bishry, Mohamed Rifaat El Fiki, Aida Seif El Dawla, and Amany Haroun El Rasheed
[Abstract] [PDF]

737 Restlessness of Respiration as a Manifestation of Akathisia: Five Case Reports of Respiratory Akathisia. Shigehiro Hirose
[Abstract] [PDF]

742 Elevated Levels of Insulin, Leptin, and Blood Lipids in Olanzapine-Treated Patients With Schizophrenia or Related Psychoses. Kristina I. Melkersson, Anna-Lena Hulting, and Kerstin E. Brismar
[Abstract] [PDF]

750 Treatment of Depression With Methylphenidate in Patients Difficult to Wean From Mechanical Ventilation in the Intensive Care Unit. Hans-Bernd Rothenhausler, Sigrid Ehrentraut, Georges von Degenfeld, Michael Weis, Monika Tichy, Erich Kilger, Christian Stoll, Gustav Schelling, and Hans-Peter Kapfhammer
[Abstract] [PDF]

756 Genetic Studies of Panic Disorder: A Review. Odile A. van den Heuvel, Ben J. M. van de Wetering, Dick J. Veltman, and David L. Pauls
[Abstract] [PDF]

767 An Algorithm for the Treatment of Schizophrenia in the Correctional Setting: The Forensic Algorithm Project. Charles A. Buscema, Qamar A. Abbasi, David J. Barry, and Timothy H. Lauve
[Abstract] [PDF]

Academic Highlights

791 Alzheimer's Disease: Translating Neurochemical Insights Into Clinical Benefits.
[PDF]

CME Article 803

804 Diagnosing Bipolar Disorder and the Effect of Antidepressants: A Naturalistic Study. S. Nassir Ghaemi, Erica E. Boiman, and Frederick K. Goodwin
[Abstract] [PDF]

Letters to the Editor

784 EMDR for Treatment of PTSD. -Gary Peterson -Nancy J. Smyth, Ricky Greenwald, Ad de Jongh, and Christopher Lee
[PDF]

  • Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances

785 Further Discussion of EMDR for Treatment of PTSD. Charles R. Figley, Andrew M. Leeds, Sandra A. TinkerWilson, and Bessel A. van der Kolk
[PDF]

  • Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances

786 Omission of Bupropion as a Recommended Treatment for PTSD. Ralph M. Reeves
[PDF]

  • Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances

787 Psychodynamic Psychotherapy for PTSD. -Jose A. Saporta-Eric M. Plakun and Edward R. Shapiro
[PDF]

  • Reply by Edna B. Foa, Jonathan R. T. Davidson, and Allen Frances

Book Reviews 789

Information for authors

see July 2000, pages 542544 or our Web site at www.psychiatrist.com/author.htm